Back to News
Mar 5, 2026 4:20 PM

Metagenomi Therapeutics Q4 Earnings Assessment

The earnings results for Metagenomi Therapeutics (NASDAQ:MGX) for Q4 were made public on Thursday, March 5, 2026 at 04:05 PM.

Here's a comprehensive overview of the announcement.

Earnings

Metagenomi Therapeutics missed estimated earnings by -3.45%, reporting an EPS of $-0.6 versus an estimate of $-0.58.

Revenue was down $5.70 million from the same period last year.

Performance in Previous Earnings

The company beat on EPS by ...